Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous versus intravenous morphine when switching from oral to parenteral treatment in palliative cancer patients
2021-003427-14Phase 4Completed
- Sponsor
- Akershus University Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of morphine in cancer pain (2 arms), sponsored by Akershus University Hospital. Primary endpoint: Time from initiation of infusion until final infusion rate. Started Nov 2021; status: completed.
02
Drugs
morphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2021-003427-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003427-14.